Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma.

× No keyword cloud information.

13 in total

1. Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Authors: J Decock; W Hendrickx; H Wildiers; M R Christiaens; P Neven; M Drijkoningen; R Paridaens
Journal: Clin Exp Metastasis Date: 2005 Impact factor: 5.150

Review 2. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors: Roopali Roy; Jiang Yang; Marsha A Moses
Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544

3. The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.

Authors: Kuvaja Paula; Talvensaari-Mattila Anne; Turpeenniemi-Hujanen Taina
Journal: Biomark Insights Date: 2007-04-03

4. Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.

Authors: Klaus Jung; Ferdinando Mannello; Michael Lein
Journal: J Transl Med Date: 2009-10-14 Impact factor: 5.531

5. Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.

Authors: S Wilson; S Damery; D D Stocken; G Dowswell; R Holder; S T Ward; V Redman; M J Wakelam; J James; F D R Hobbs; T Ismail
Journal: Br J Cancer Date: 2012-03-20 Impact factor: 7.640

6. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.

Authors: Kawin Leelawat; Sompong Sakchinabut; Siriluck Narong; Jerasak Wannaprasert
Journal: BMC Gastroenterol Date: 2009-04-30 Impact factor: 3.067

Review 7. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors: László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal: Int J Mol Sci Date: 2012-10-16 Impact factor: 5.923

8. Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.

Authors: S Damery; L Nichols; R Holder; S T Ward; S Warmington; S Wilson; M J Wakelam; J James; T Ismail
Journal: Br J Cancer Date: 2013-02-07 Impact factor: 7.640

9. Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.

Authors: K Jung
Journal: Br J Cancer Date: 2008-07-22 Impact factor: 7.640

10. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.

Authors: Javier Cotignola; Boris Reva; Nandita Mitra; Nicole Ishill; Shaokun Chuai; Ami Patel; Shivang Shah; Gretchen Vanderbeek; Daniel Coit; Klaus Busam; Allan Halpern; Alan Houghton; Chris Sander; Marianne Berwick; Irene Orlow
Journal: BMC Med Genet Date: 2007-03-08 Impact factor: 2.103